Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-09-000099
Filing Date
2009-11-20
Accepted
2009-11-20 16:37:40
Documents
1
Period of Report
2009-11-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3751
  Complete submission text file 0000875320-09-000099.txt   5423
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139
Business Address
Silva Paul M (Reporting) CIK: 0001446372 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 091199088